FN2 Earnings Intelligence
Medtronic plc income statement (quarterly)
Medtronic plc (MDT) Income Statement (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 10/25/2024 | 1/24/2025 | 7/25/2025 | 10/24/2025 | 1/23/2026 | 1/24/2026 est. | 4/24/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $1,394 | $1,240 | $1,273 | $1,282 | $1,147 | - | - |
| + Debt | $5,651 | $4,554 | $4,362 | $3,352 | $2,123 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $8,403 | $8,292 | $8,578 | $8,961 | $9,017 | $8,910.9 | $9,620.2 |
| % Growth | - | - | - | - | - | 7.5% | - |
| Gross Profit | $5,457 | $5,513 | $5,577 | $5,900 | $5,756 | - | - |
| % Margin | 64.9% | 66.5% | 65.0% | 65.8% | 63.8% | - | - |
| EBITDA | - | - | $2,193 | $1,968 | $1,772 | - | - |
| % Margin | - | - | 25.6% | 22.0% | 19.7% | - | - |
| Net Income | $1,270 | $1,294 | $1,040 | $1,374 | $1,143 | - | - |
| % Margin | 15.1% | 15.6% | 12.1% | 15.3% | 12.7% | - | - |
| Diluted EPS | $0.99 | $1.01 | $0.81 | $1.07 | $0.89 | $1.34 | $1.54 |
| % Growth | - | - | - | - | - | 32.4% | - |
| Operating Cash Flow | - | - | $1,088 | - | - | - | - |
| CapEx | - | - | $504 | - | - | - | - |
| Free Cash Flow | - | - | $584 | - | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 10/25/2024 | 1/24/2025 | 7/25/2025 | 10/24/2025 | 1/23/2026 | 1/24/2026 est. | 4/24/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $8,403 | $8,292 | $8,578 | $8,961 | $9,017 | $8,910.9 | $9,620.2 |
| Gross Profit | $5,457 | $5,513 | $5,577 | $5,900 | $5,756 | - | - |
| EBITDA | - | - | $2,193 | $1,968 | $1,772 | - | - |
| Net Income | $1,270 | $1,294 | $1,040 | $1,374 | $1,143 | - | - |
| Diluted EPS | $0.99 | $1.01 | $0.81 | $1.07 | $0.89 | $1.34 | $1.54 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 10/25/2024 | 1/24/2025 | 7/25/2025 | 10/24/2025 | 1/23/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,394 | $1,240 | $1,273 | $1,282 | $1,147 |
| Short-term Debt | $3,719 | $2,622 | $2,430 | $1,420 | $191 |
| Long-term Debt | $1,932 | $1,932 | $1,932 | $1,932 | $1,932 |
| Total Debt | $5,651 | $4,554 | $4,362 | $3,352 | $2,123 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 10/25/2024 | 1/24/2025 | 7/25/2025 | 10/24/2025 | 1/23/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $1,088 | - | - |
| Capital Expenditure | - | - | $504 | - | - |
| Free Cash Flow | - | - | $584 | - | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 10/25/2024 | 1/24/2025 | 7/25/2025 | 10/24/2025 | 1/23/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 64.9% | 66.5% | 65.0% | 65.8% | 63.8% |
| EBITDA Margin | - | - | 25.6% | 22.0% | 19.7% |
| Net Margin | 15.1% | 15.6% | 12.1% | 15.3% | 12.7% |
| FCF Margin | - | - | 6.8% | - | - |
| Diluted EPS Growth | - | - | - | - | - |